Unproven treatments for COVID-19 have strained supplies for lupus patients.
A new study claims one in four Texans had treatments and drugs denied by insurance companies even though doctors said they were necessary.
To ensure the ongoing affordability of generic medications for Americans, BCBS is committing $55 million to establish a partnership with Civica Rx to reduce costs of generics for consumers.
Purdue Pharma, the maker of OxyContin, declared bankruptcy as part of a tentative deal to settle more than 2,000 lawsuits alleging that they and other opioid manufacturers worsened the US opioid epidemic.
The opioid crisis is not just an American problem; it’s a global one.